Softgel Healthcare Private Limited Docusate Export Data — India (DGFT 2022–2026)

Name: Softgel Healthcare Private Limited Docusate Export Records India — #10 Exporter, 4 Shipments, $48.9K FOB USD (DGFT 2022–2026)
Creator: TransData Nexus
Published: 2026-04-01T00:00:00Z
License: https://transdatanexus.com/terms-and-conditions

Suresh Sormare

Docusate

India Pharmaceutical Trade Intelligence

$9.3M25 Suppliers35 CountriesHS 30049039

ExportsIndia → UNITED STATES84.6%India → AUSTRALIA12.9%

ImportsUNITED KINGDOM → India$324 JAPAN → India$71

#1 Supplier: TRUECARE BIOMEDIX #1 Buyer: PL DEVELOPMENTS

Softgel Healthcare Private Limited — Docusate Exporter #10 | $48.9K Trade Value | TransData Nexus | TransData Nexus

Softgel Healthcare Private Limited — Docusate Exporter Profile

Indian Pharmaceutical Exporter · #10 for Docusate · $48.9K export value · DGFT Verified

Softgel Healthcare Private Limited is the #10 Indian exporter of Docusate with $48.9K in export value and 4 verified shipments. Softgel Healthcare Private Limited holds a 0.5% market share in Docusate exports across 1 countries. The company exports 6 pharmaceutical products worth $11.5M across 4 therapeutic categories.

Softgel Healthcare Private Limited — Docusate Export Profile: Buyers & Destinations

Softgel Healthcare Private Limited Docusate export treemap — buyers and destination countries | TransData Nexus

Where Does India Export Docusate?

Country	Value	Shipments	Share
UNITED STATES	$7.8M	234	84.6%
AUSTRALIA	$1.2M	81	12.9%
CANADA	$134.6K	12	1.5%
VENEZUELA	$28.3K	1	0.3%

Who Are the Top Buyers of Docusate from India?

Buyer	Country	Value	Orders
PL DEVELOPMENTS	UNITED STATES	$5.0M	99
GERICARE PHARMACEUTICALS CORP.	UNITED STATES	$1.2M	32
GENERIC HEALTH	AUSTRALIA	$371.2K	11
APOTEX AUSTRALIA	AUSTRALIA	$329.2K	34
GERICARE PHARMACEUTICALS CORP	UNITED STATES	$300.0K	6
NOUMED PHARMACEUTICALS PTY LTD	AUSTRALIA	$172.6K	10
NOUMED PHARMACEUTICALS PTY LIMITED	AUSTRALIA	$148.3K	12
GERICARE PHARMACEUTICALS	UNITED STATES	$145.8K	6
STRIVE PHARMACEUTICALS	UNITED STATES	$141.3K	8
PRIVATE LIMITED DEVELOPMENTS	UNITED STATES	$100.0K	2

India's Docusate is purchased by 158 buyers worldwide. The top buyer is PL DEVELOPMENTS (UNITED STATES), followed by GERICARE PHARMACEUTICALS CORP. and GENERIC HEALTH.

How Does Softgel Healthcare Private Limited Compare to Nearest Docusate Exporters?

Exporters ranked immediately above and below #10 by export value

#	Supplier	Export Value	Shipments	Countries	Avg/Shipment
8	ALDER BIOCHEM PRIVATE LIMITED	$109.8K	8	1	$13.7K
9	MARKSANS PHARMA LIMITED	$102.5K	6	1	$17.1K
10	SOFTGEL HEALTHCARE PRIVATE LIMITED ★	$48.9K	4	1	$12.2K
11	ELYSIUM PHARMACEUTICALS LIMITED	$44.1K	3	1	$14.7K

Softgel Healthcare Private Limited ranks #10 among 25 Indian Docusate exporters. Average shipment value of $12.2K compared to the market average of $353.6K. The closest competitors by value are ALDER BIOCHEM PRIVATE LIMITED and MARKSANS PHARMA LIMITED.

Which Indian Ports Ship Docusate Exports?

Port	Shipments	% Share
SAHAR AIR	79	17.4%
MUNDRA SEA	68	15.0%
MUNDRA SEA (INMUN1)	50	11.0%
SAHAR AIR CARGO ACC (INBOM4)	48	10.6%
Bombay Air	20	4.4%
JNPT	17	3.8%
JNPT/ NHAVA SHEVA SEA	17	3.8%
AHEMDABAD ICD	16	3.5%

Geopolitical & Trade Policy Impact on Softgel Healthcare Private Limited's Docusate Exports

The current geopolitical landscape presents both challenges and opportunities for Indian pharmaceutical exporters like SHPL. The Israel-Iran conflict has led to disruptions in Red Sea shipping routes, causing increased freight charges and extended transit times. These logistical challenges are particularly impactful for time-sensitive pharmaceutical shipments, potentially leading to supply chain disruptions and financial losses estimated between ₹2,500 crore and ₹5,000 crore in March 2026. (fortuneindia.com)

Conversely, trade tensions between the US and China have opened avenues for Indian pharmaceutical companies to expand their footprint in the US market. However, the imposition of tariffs on pharmaceutical imports by the US poses a significant risk. In August 2025, the US administration imposed broad tariffs on imports from over 60 countries, including India, with rates reaching as high as 39%. This move has raised concerns among Indian exporters about increased costs and potential loss of market share. (apnews.com)

In the European Union, compliance with the Falsified Medicines Directive (FMD) remains a critical requirement. Indian exporters must ensure adherence to these regulations to maintain access to the EU market. The India–EFTA Trade and Economic Partnership Agreement, signed in March 2024 and effective from October 2025, aims to eliminate or reduce tariffs on goods traded between India and EFTA countries, potentially benefiting exporters like SHPL. (en.wikipedia.org)

Softgel Healthcare Private Limited — Regulatory Compliance & Quality Standards

Maintaining compliance with international regulatory standards is imperative for Indian pharmaceutical exporters. The US FDA has intensified inspections, conducting over 200 in 2023, with plans to increase this number in 2024. This heightened scrutiny underscores the necessity for robust quality control systems. (fact.net.in)

SHPL's adherence to globally recognized certifications, such as USFDA, TGA, and EU-GMP, positions the company favorably in this stringent regulatory environment. Continuous investment in quality assurance and compliance infrastructure is essential to sustain and expand its export markets.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Analysis Methodology

1.Product Matching: Docusate shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
2.Supplier Identification: Softgel Healthcare Private Limited matched across shipments using name normalization, accounting for company name formatting variations.
3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.

Government-Sourced Data

Official DGFT customs records

Transparent Methodology

Calculations fully disclosed above

Global Coverage

Exports to 35+ countries, 158+ buyers

Expert-Reviewed

Analyzed by pharmaceutical trade specialists

Docusate

Docusate

Softgel Healthcare Private Limited — Docusate Exporter Profile

Softgel Healthcare Private Limited — Docusate Export Profile: Buyers & Destinations

Where Does India Export Docusate?

Who Are the Top Buyers of Docusate from India?

What Is India's Total Docusate Export Value and How Much Does Softgel Healthcare Private Limited Contribute?

What Is the Average Shipment Value for Softgel Healthcare Private Limited's Docusate Exports?

How Does Softgel Healthcare Private Limited Compare to Other Indian Docusate Exporters?

Regulatory Requirements: Exporting Docusate to Key Markets

United States — FDA

Australia — TGA

How Does Softgel Healthcare Private Limited Compare to Nearest Docusate Exporters?

Which Indian Ports Ship Docusate Exports?

Geopolitical & Trade Policy Impact on Softgel Healthcare Private Limited's Docusate Exports

Softgel Healthcare Private Limited — Regulatory Compliance & Quality Standards

About Softgel Healthcare Private Limited

Market Intelligence

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

Analysis Methodology

Get Docusate Export Data from Softgel Healthcare Private Limited

Docusate Stats

Company Overview

Top Products by Softgel Healthcare Private Limited

Related Analysis

Need Detailed Export Data?

Data Source